Placebo Clinical Trial
Official title:
Acute Effects on Creatine Kinase, Perceived Fatigue and Physical Performance of Different Post-Exercise Recovery Methods in Elite Basketball Players: A Crossover Randomized Controlled Trial
Verified date | March 2023 |
Source | University of Cadiz |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study was to compare the effects of cold water intermittent ion (CWI), carbohydrate and protein supplementation (SUPPL), and active recovery (ACT) on creatine kinase (CK), perceptual and performance markers of recovery in elite basketball players after a specific fatigue protocol. Fifteen elite basketball players participated in this crossover controlled trial. All participants were randomly measured in 4 conditions of the recovery method 1 week apart after a fatigue exercise protocol (~ 45 'of high intensity intermittent effort with specific basketball movements). The recovery methods consist of CWI at 10oC in periods of 2 minutes submerged and 2 minutes out of the water, supplementation with 0.3gr / kg of maltodextrin and 0.2gr / kg of neutral whey protein in 0.5 liters of water, pedaling ACT for 25 minutes at 50% of maximum heart rate or a placebo drink (PLA). The Visual Analogue Fatigue Scale (VAS), Perceived Exercise Rate (RPE), CK and physical performance (jumping, speed, isometric and dynamic tests of resistance to squats) were measured before, after and 24 hours after of the protocol. The VAS scale and RPE were also measured immediately after application of the recovery method. Repeated 2-way post-hoc comparisons of ANOVA and Bonferroni measures were applied, with a significance set at P <0.05.
Status | Completed |
Enrollment | 15 |
Est. completion date | March 28, 2017 |
Est. primary completion date | March 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Having at least 10 years of sports practice, - Having been training during the season a minimum of four times a week, - Not having suffered serious or minor but recently injuries, - Having competed and trained regularly in the previous season. Exclusion Criteria: - Suffering an injury during the study period - Not having gone through all the treatment groups (CWI, carbohydrate-protein supplementation, active recovery and placebo) |
Country | Name | City | State |
---|---|---|---|
Spain | Science of Education Faculty | Puerto Real | Cadiz |
Lead Sponsor | Collaborator |
---|---|
University of Cadiz |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Creatine Kinase (CK) | Blood samples were obtained from the earlobe and collected into capillary tubes. Serum creatine kinase activity was analyzed with Reflotron ® Plus - Roche | 4 Weeks | |
Primary | Fatigue perception | The VAS fatigue scale (VAS) was used and evaluated on a scale from 1 to 10 (1 = no fatigue and 10 = extremely fatigued). | 4 Weeks | |
Primary | Rate of Perceived Exertion | The Rate of Perceived Exertion Scale (RPE) was used and evaluated on a scale from 1 to 10 (1 = no exertion and 10 = extremely hard). | 4 Weeks | |
Primary | 10 meters sprint time | 10m Sprint Test was used and subjects ran 10m maximally. The subjects had 2 attempts to achieve their best performance with 1 minute of rest between trials. Time was recorded with a video analysis. | 4 Weeks | |
Primary | 4 x 10 meters agility time | 4 x 10m Agility Test was used and subjects had to run as fast as possible between two cones 10 meters apart four times. The subjects had 2 attempts to achieve their best performance with 1 minute of rest between trials. Time was recorded with a video analysis. | 4 Weeks | |
Primary | Squat Jump | The flight time in jumps height and its maximal speed were used as a measure of maximal muscle power and was measured on a force platform (Quattro Jump, Kristler). In squat jump, the subjects were asked to keep their hands on their hips and beginning the jump with a 90º knee flexion, without countermovement. Subjects had 2 attempts to achieve their best jump with 3 minutes of rest between trials. | 4 Weeks | |
Primary | Counter Movement Jump | The flight time in jumps height and its maximal speed were used as a measure of maximal muscle power and was measured on a force platform (Quattro Jump, Kristler). In countermovement jump, subjects were only asked to keep their hands on their hips and jump as high as possible, with countermovement. Subjects had 2 attempts to achieve their best jump with 3 minutes of rest between trials. | 4 Weeks | |
Primary | Abalakov Jump | The flight time in jumps height and its maximal speed were used as a measure of maximal muscle power and was measured on a force platform (Quattro Jump, Kristler). Abalakov jump was performed with free arms movement and countermovement. Subjects had 2 attempts to achieve their best jump with 3 minutes of rest between trials. | 4 Weeks | |
Primary | Half Squat Isometric Strength | In the maximal isometric strength test, the subjects performed a maximal isometric contraction in the half squat exercise, with 90º knee flexion. The strength of the subjects was measured with a force platform on which the exercise was performed. The subjects were asked to perform the maximal strength possible since the start and to not stop until a signal. They had 2 attempts to achieve their best performance with 3 minutes of rest between trials. | 4 Weeks | |
Primary | Half Squat Dynamic Strength | In the dynamic strength test, the subjects performed 6 repetitions of a half squat, using a Smith Machine, with the load that represented the 70% of RM (0.65 m·s) at baseline in the half squat exercise. The mean velocity was measured with a linear encoder and it was registered the fastest repetition. The subjects were asked to perform the concentric action as fast as possible. They had 2 attempts to achieve their best performance with 3 minutes of rest between trials. | 4 Weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04852315 -
Acute Caffeine Ingestion on Futsal Performance
|
N/A | |
Completed |
NCT05427409 -
Ingestion of Beta-alanine Effects in Well-trained Tennis Players
|
N/A | |
Completed |
NCT05425563 -
Effects of Expectations on Negative Affect, Perceived Cognitive Effort, and Pain
|
N/A | |
Recruiting |
NCT05007561 -
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
|
Early Phase 1 | |
Recruiting |
NCT04851301 -
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
|
Phase 1/Phase 2 | |
Recruiting |
NCT03897998 -
Neural Correlates of Hypoalgesia Driven by Observation
|
Phase 2 | |
Completed |
NCT04359147 -
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
|
N/A | |
Recruiting |
NCT05145764 -
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
|
Phase 2 | |
Completed |
NCT01167478 -
Neurophysiological Reserve With Caffeine Manipulation
|
N/A | |
Completed |
NCT05337527 -
Neuromuscular Responses to Acute Beetroot Ingestion in Women Older Adults
|
N/A | |
Terminated |
NCT01656577 -
Pexacerfont for Stress-induced Food Craving
|
Phase 0 | |
Completed |
NCT04361968 -
Combining Animal-assisted Intervention and Placebo-induced Analgesia
|
N/A | |
Completed |
NCT03754062 -
Pharmacological Modulation of Belief Salience
|
Phase 1 | |
Not yet recruiting |
NCT04317157 -
Placebo Effects Investigated by Different Experimental Designs
|
N/A | |
Completed |
NCT01361633 -
The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
|
Phase 2 | |
Completed |
NCT05209126 -
Impact of Beetroot Juice Ingestion on Female Rugby Performance
|
N/A | |
Completed |
NCT05521347 -
Caffeine Supplementation Improves the Cognitive Abilities and Shooting Performance of Trained E-sports Players
|
N/A | |
Completed |
NCT04975360 -
Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening
|
N/A | |
Completed |
NCT04671043 -
Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes
|
N/A | |
Completed |
NCT01011465 -
The Biology of Resilience
|
N/A |